Delving into the details, we found 43% of traders were bullish, while 35% showed bearish tendencies. Out of all the trades we spotted, 9 were puts, with a value of $757,098, and 30 were calls, valued ...

Saia's valuation stays quite reasonable but fully priced, limiting upside potential. Click here to find out why SAIA stock is a Hold.

As of Wednesday, February 25, Iovance Biotherapeutics, Inc.’s IOVA share price has surged by 10.85%, which has investors questioning if this is right time to sell.

The sell-offs in bellwether stocks, including BUA Foods Plc, MTN Nigeria Communications Plc and Stanbic IBTC Holdings Plc, weighed heavily on the Nigerian equities market on Tuesday, erasing about N1.

Inc. Common Stock with 15,198 calls trading, 4x expected, and implied vol increasing over 2 points to 166.59%. Mar-26 12 calls and Mar-26 14 calls are the most active options, with total volume in ...

Get the latest Pashupati Cotspin share price today on NSE & BSE. Explore Pashupati Cotspin stock analysis, financial performance, market capitalization, dividend history, and future outlook for ...

Stay informed with the Titan Company Stock Liveblog, your comprehensive resource for real-time updates and in-depth analysis ...

Welcome to the JSW Steel Stock Liveblog, your go-to platform for real-time updates and analysis on a top-performing stock.

Chief Executive Officer — Harout Semerjian Chief Commercial Officer — Ahmed ElNawawi Executive Vice President, Research and Development and Chief Medical Officer — Joseph Eid Chief Financial Officer — ...

Payoneer Global Inc. will report fourth-quarter and full-year 2025 results Thursday before the market opens, a closely watched report for investors trying to assess whether the cross-border payments ...

Get the latest Usha Martin share price today on NSE & BSE. Explore Usha Martin stock analysis, financial performance, market capitalization, dividend history, and future outlook for investors in India ...

Balance sheet concerns persist. Ardagh’s leverage remains elevated at 5.2x net debt/EBITDA, with dividends funded by debt and no positive free cash flow coverage. Any commentary on deleveraging ...